These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
227 related items for PubMed ID: 812544
1. Protective properties and haemagglutinins in serum from humans and in serum from mice injected with a new polyvalent Pseudomonas vaccine. Jones RJ, Roe EA. Br J Exp Pathol; 1975 Feb; 56(1):34-43. PubMed ID: 812544 [Abstract] [Full Text] [Related]
2. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers]. Bbukowska D, Serafińska D, Rudowski W, Hoffman S, Olański W, Gardzińska E, Popiel D, Jedrzejczak G, Czarnecka I. Pol Tyg Lek; 1975 Feb; 44(43-45):924-7. PubMed ID: 2518666 [Abstract] [Full Text] [Related]
7. Protection against Pseudomonas aeruginosa infection by immunisation with fractions of culture filtrates of Ps. aeruginosa. Jones RJ. Br J Exp Pathol; 1968 Oct; 49(5):411-20. PubMed ID: 4973304 [No Abstract] [Full Text] [Related]
11. Common protective antigen between Pseudomanas aeruginosa and Vibrio cholerae. Yamamoto A, Homma JY, Ghoda A, Ishihara T, Takeuchi S. Jpn J Exp Med; 1979 Dec; 49(6):383-90. PubMed ID: 120454 [Abstract] [Full Text] [Related]
12. Characterisation of mouse monoclonal antibodies produced by immunisation with a single serotype component of a polyvalent Pseudomonas aeruginosa vaccine. Barclay GR, Yap PL, McClelland DB, Jones RJ, Roe EA, McCann MC, Micklem LR, James K. J Med Microbiol; 1986 Feb; 21(1):87-90. PubMed ID: 3081727 [Abstract] [Full Text] [Related]
13. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection. Faezi S, Safarloo M, Amirmozafari N, Nikokar I, Siadat SD, Holder IA, Mahdavi M. APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581 [Abstract] [Full Text] [Related]
14. Protective effects of affinity-purified antibody and truncated vaccines against Pseudomonas aeruginosa V-antigen in neutropenic mice. Moriyama K, Wiener-Kronish JP, Sawa T. Microbiol Immunol; 2009 Nov; 53(11):587-94. PubMed ID: 19903258 [Abstract] [Full Text] [Related]
15. [Immunogenic properties of a polyvalent vaccine against Pseudomonas aeruginosa]. Serafińska D, Bukowska D, Sokołowska K, Nasiłowski W. Pol Tyg Lek; 1980 Jul 07; 35(27):1013-5. PubMed ID: 6775310 [No Abstract] [Full Text] [Related]
16. Active and passive mouse-protecting capacity of Pseudomonas aeruginosa protein vaccines. Joó I, Stanislavsky ES, Zhvanetskaya MI, Mashilova GM, Gladus MA. Acta Microbiol Acad Sci Hung; 1982 Jul 07; 29(4):267-75. PubMed ID: 6821018 [Abstract] [Full Text] [Related]
17. Induction in mice of cell-mediated immunity to Pseudomonas aeruginosa by high molecular weight polysaccharide and vinblastine. Pier GB, Markham RB. J Immunol; 1982 May 07; 128(5):2121-5. PubMed ID: 6174622 [Abstract] [Full Text] [Related]
18. An acellular vaccine from Pseudomonas aeruginosa: homologous and crossed protection between serogroups according to Habs' classification. Berche P, Véron M, Fermanian J, Daoulas-Lebourdelles F, Guégen A. Ann Microbiol (Paris); 1979 May 07; 130(2):179-88. PubMed ID: 90473 [Abstract] [Full Text] [Related]